Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | FBIO | AMGN | VRTX | GILD | BMY |
| Company | Fortress Biotech Inc | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.9900 | 320.58 | 473.91 | 89.49 | 54.33 |
| High | 1.9900 | 320.58 | 475.48 | 90.71 | 55.77 |
| Low | 1.7000 | 314.61 | 469.48 | 89.37 | 54.32 |
| Last | 1.7100 | 317.15 | 471.51 | 90.40 | 55.22 |
| Change | -0.1900 | -2.07 | +0.39 | +0.89 | +0.90 |
| % Change | -10.00% | -0.65% | +0.08% | +0.99% | +1.66% |
| Volume | 1,246,873 | 650,320 | 370,448 | 2,942,179 | 5,051,725 |
| 20-Day Average Volume | 588,578 | 1,647,877 | 1,006,853 | 5,022,743 | 8,448,591 |
| Previous Close | 1.9000 | 319.22 | 471.12 | 89.51 | 54.32 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7782 | 319.63 | 476.82 | 87.31 | 53.05 |
| 20-Day Raw Stochastic | 37.50% | 33.17% | 43.27% | 98.47% | 80.88% |
| 20-Day Relative Strength | 47.57% | 45.42% | 48.71% | 70.63% | 62.19% |
| Weighted Alpha | -23.74 | +15.49 | +22.65 | +28.41 | +16.29 |
| Today's Opinion | 72% Sell | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 8% Buy | 8% Buy | 24% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 24% Buy | 8% Buy | 88% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.60% since 10/28/24 | -0.12% since 10/28/24 | -0.94% since 10/28/24 | +2.08% since 10/28/24 | +4.99% since 10/28/24 |
| Low | 1.7000 on 11/04/24 | 310.63 on 10/30/24 | 463.14 on 11/01/24 | 86.81 on 10/29/24 | 52.14 on 10/29/24 |
| High | 2.1000 on 10/29/24 | 323.40 on 10/31/24 | 478.06 on 10/29/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 1-Month | |||||
| %Chg | +5.83% since 10/04/24 | -0.90% since 10/04/24 | +3.64% since 10/04/24 | +7.12% since 10/04/24 | +2.42% since 10/04/24 |
| Low | 1.5000 on 10/08/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 84.17 on 10/11/24 | 51.31 on 10/15/24 |
| High | 2.1000 on 10/29/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 3-Month | |||||
| %Chg | -9.69% since 08/02/24 | -5.15% since 08/02/24 | -4.57% since 08/02/24 | +18.03% since 08/02/24 | +13.32% since 08/02/24 |
| Low | 1.3550 on 09/24/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 72.43 on 08/12/24 | 46.22 on 08/08/24 |
| High | 2.1599 on 08/27/24 | 339.17 on 09/23/24 | 500.25 on 08/30/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| 6-Month | |||||
| %Chg | -1.43% since 05/03/24 | +1.76% since 05/03/24 | +17.65% since 05/03/24 | +39.87% since 05/03/24 | +25.63% since 05/03/24 |
| Low | 1.3550 on 09/24/24 | 295.30 on 06/13/24 | 394.03 on 05/07/24 | 62.07 on 05/31/24 | 39.35 on 07/05/24 |
| High | 2.8900 on 07/23/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 90.71 on 11/04/24 | 56.20 on 10/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 43,347 | 171,526,160 | 121,597,008 | 111,439,232 | 110,128,096 |
| Shares Outstanding, K | 22,814 | 537,329 | 258,102 | 1,244,992 | 2,027,395 |
| Annual Sales | 84,510,000 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -60,640,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 14,900,000 | 8,388,000,000 | 2,645,600,000 | 6,954,000,000 | 12,201,000,000 |
| Last Quarter Net Income | -10,950,000 | 746,000,000 | -3,593,600,000 | 1,614,000,000 | 1,680,000,000 |
| 60-Month Beta | 1.75 | 0.60 | 0.39 | 0.17 | 0.44 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.73 on 08/13/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 2.01 on 08/08/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 09/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.66 | 0.00 | 18.90 | 47.67 |